Number of the records: 1
A dark side to NS1 antibodies?
- 1.0554924 - BC 2023 RIV US eng O - Others
Robbiani, D.F. - Růžek, Daniel
A dark side to NS1 antibodies?
2021. Journal of Experimental Medicine. Rockefeller University Press. Roč. 218, č. 9 (2021), č. článku e20211348. ISSN 0022-1007. E-ISSN 1540-9538
R&D Projects: GA ČR(CZ) GA20-14325S; GA ČR(CZ) GF21-05445L
Institutional support: RVO:60077344
Keywords : monoclonal-antibodies
OECD category: Immunology
Method of publishing: Open access
https://rupress.org/jem/article/218/9/e20211348/212515/A-dark-side-to-NS1-antibodies-A-dark-side-to-NS1
The NS1 protein of flaviviruses is taking center stage. Recent work has made it an attractive target for development of vaccines and immunotherapeutics. Cavazzoni and colleagues (2021. J. Exp. Med. https://doi.org/10.1084/jem. 20210580) now reveal a dark side to NS1, linking it to the development of self-reactive antibodies.
Permanent Link: http://hdl.handle.net/11104/0329541
Number of the records: 1